Skip to main content

Table 1 Main characteristics of the study population at inclusion (N = 368)

From: A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations

Parameter (N = 368) Category IDUs N (%) nIDUs N (%)
Gender Male 248/310 (80.0) 47/58 (81.1)
Nationality Luxembourg 183/310 (59.0) 24/58 (41.4)
  Portugal 60/310 (19.3) 13/58 (22.4)
Children at charge Yes 54/310 (17.4) 9/58 (15.5)
Life time drug use Heroin 279/279 (100.0) 28/28 (100.0)
  Cocaine 280/310 (90.3) 37/58 (63.8)
  Cannabis 286/334 (85.6) 48/334 (14.4)
  Speedball
(heroin/cocaine combination)
205/310 (84.2) 0/58 (0.0)
Last 6 months IDU Never borrowed used paraphernalia 162/256 (63.3)  
  Never lend used paraphernalia 161/255 (62.9)  
  Mostly shared: cups 69/94 (73.4)  
  Mostly shared: filters 68/94 (72.3)  
  Mostly shared: syringes 42/94 (44.6)  
Last 6 months number of sexual partners (N = 266) None 192/308 (62.3) 32/58 (55.2)
  1-9 94/308 (30.5) 26/58 (44.8)
  10+ 22/308 (7.1) 0/58 (0)
Imprisonment (N = 366) At least once during the last 10 years 215/308 (69.8) 31/58 (53.4)
Drug consumption in prison (N = 246) Yes 130/215 (60.5) 8/31 (25.8)
Substitution treatment (N = 368) Yes 286/310 (92.3) 19/58 (32.8))
Tattoo or piercing None 87/309 (28.2) 28/58 (48.3)
  Tattoo 100/309(32.4) 14/58 (24.1)
  Piercing 23/309 (7.4) 9/58 (15.5)
  Both 99/309 (32.0) 7/58 (12.1)
  1. Note: Denominators may vary because of missing answers to some questions.